Yes, that's positive. I look forward to that update.

Turning to another issue linked to the slow pace of the introduction of new technologies, the use of multiparametric MRI in the diagnosis of prostate cancer, you will be aware—very aware—that the clinical consensus is that this is a game changer, a real game changer, in the diagnosis of prostate cancer. But only two health boards in Wales are providing mpMRI to a high enough standard to avoid the need for biopsy. The result is that many men have chosen—have been forced, in effect—to pay upwards of £900 for private mpMRI scans.

Now, when asked about this before, you said that you were waiting for updated guidelines from NICE, but they won't be published until April next year, and at the same time England and Scotland have introduced this generally. Now, why is it in cases where I suspect you know really that the conclusions of NICE will be to propose pressing forward with this, and where other NHS services in the UK are using new technologies—why is it that you're content for Welsh patients to wait until the judgment and then wait for the implementation period?